Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis
2015
Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric
2017
2017
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Inference and analysis of cell-cell communication using CellChat
2021 Standout
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Inflammatory breast cancer: a model for investigating cluster-based dissemination
2017
Establishing the Diagnosis of Lung Cancer
2013 Standout
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
2015 Standout
Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
2017
Hybrid epithelial/mesenchymal phenotype(s): The ‘fittest’ for metastasis?
2018
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
xCell: digitally portraying the tissue cellular heterogeneity landscape
2017 Standout
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Molecular Biology of Lung Cancer
2013
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury
2012 Standout
Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
2015
Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer
2012
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
2012
Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy
2016
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Polymer-Based Cancer Nanotheranostics: Retrospectives of Multi-Functionalities and Pharmacokinetics
2013
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
EMT: 2016
2016 Standout
Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549
2018
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction
2014
The cancer stem cell: premises, promises and challenges
2011 Standout
Casticin suppresses self-renewal and invasion of lung cancer stem-like cells from A549 cells through down-regulation of pAkt
2013
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
2010
Cisplatin: The first metal based anticancer drug
2019 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Tackling the cancer stem cells — what challenges do they pose?
2014
Blockade of Cd47-Mediated Cathepsin S/Protease-Activated Receptor 2 Signaling Provides a Therapeutic Target for Hepatocellular Carcinoma
2014
Idiopathic pulmonary fibrosis
2011 Standout
Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
2010
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice
2011
Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: Potential role of hypoxia
2012
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
2008
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression
2017
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Tumor Budding: The Name is EMT. Partial EMT.
2016
Targeting cancer stem cells: a new therapy to cure cancer patients.
2012
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities
2019
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Combination therapy in combating cancer
2017 Standout
Relationship between CD44high/CD133high/CD117high cancer stem cells phenotype and Cetuximab and Paclitaxel treatment response in head and neck cancer cell lines.
2018
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review
2018 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance
2010
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Flavonoids in Cancer and Apoptosis
2018 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Stability of the hybrid epithelial/mesenchymal phenotype
2016
Using SV119‐Gold Nanocage Conjugates to Eradicate Cancer Stem Cells Through a Combination of Photothermal and Chemo Therapies
2014
Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways
2017
Breast Cancer‐Derived Exosomes Reflect the Cell‐of‐Origin Phenotype
2019
Works of Roberto Caserini being referenced
Conversion to stem‐cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells
2015
Inactivation of Both FHIT and p53 Cooperate in Deregulating Proliferation-Related Pathways in Lung Cancer
2012
Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatment
2009